Expand GSK Menu
GSK MENU

GSK Latest Press Releases

-- May 7, 2026 --

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults Business Wire 8:00 AM

-- March 13, 2026 --

GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk Business Wire 11:44 AM

-- March 11, 2026 --

Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production PRNewswire 6:00 AM

-- February 23, 2026 --

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract Business Wire 1:15 PM

-- February 18, 2026 --

GSK's AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows Business Wire 8:00 AM

-- February 5, 2026 --

RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT Business Wire 5:30 PM

-- January 21, 2026 --

RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT Business Wire 4:48 PM
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026 Business Wire 10:00 AM

-- January 20, 2026 --

Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK Globe Newswire 2:13 PM
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million Business Wire 9:00 AM

-- January 12, 2026 --

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate (ADC) Business Wire 6:15 AM
Market Data Delayed 15 Minutes